FDA Announces Launch Of DSCSA Supply Chain Security Pilot Program
FDA is accepting applications from the pharmaceutical industry to pilot electronic tracking systems for prescription drugs in preparation for a Nov. 27, 2023, implementation deadline.
You may also be interested in...
A blockchain application for mobile devices was successfully piloted to conduct real-time tracking of a high-cost drug through the “last mile” of the supply chain to the point of dispensing. Such a tool can be useful for manufacturers in tracing their products through the supply chain and complying with a forthcoming mandate of the US FDA Drug Supply Chain Security Act (DSCSA).
A pharmaceutical industry consortium gives the thumbs up for using blockchain technology to track and trace products through the supply chain to meet DSCSA mandate, yet says new standards are necessary.
Florida’s Importation Plan: 45% Markup On Canadian Prices Expected To Cover Costs And Produce Savings
Plan will be limited to purchases by state agencies and organizations. Drugs considered eligible for importation include treatments for HIV, multiple sclerosis and epilepsy.